Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 120491
Published online Aug 27, 2026. doi: 10.4240/wjgs.120491
Published online Aug 27, 2026. doi: 10.4240/wjgs.120491
Table 1 Comparison of general data between two groups, mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | Statistic | P value |
| Age (years) | 56.8 ± 12.4 | 55.3 ± 13.1 | t = 0.580 | 0.563 |
| Gender, male, n (%) | 31 (63.3) | 29 (59.2) | χ2 = 0.173 | 0.677 |
| BMI (kg/m2) | 23.5 ± 3.2 | 24.1 ± 3.5 | t = 0.879 | 0.382 |
| APACHE II score | 18.6 ± 4.8 | 17.9 ± 5.1 | t = 0.698 | 0.487 |
| SOFA score | 7.2 ± 2.3 | 6.9 ± 2.1 | t = 0.670 | 0.504 |
| Perforation size (cm) | 1.8 ± 0.7 | 1.9 ± 0.8 | t = 0.654 | 0.514 |
Table 2 Comparison of inflammatory markers between two groups, mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | t value | P value |
| PCT on admission (ng/mL) | 12.8 ± 5.6 | 13.2 ± 6.1 | 0.336 | 0.738 |
| PCT on POD 3 (ng/mL) | 6.4 ± 3.2 | 4.8 ± 2.5 | 2.746 | 0.007 |
| PCT on POD 5 (ng/mL) | 3.1 ± 1.8 | 1.9 ± 1.2 | 3.858 | < 0.001 |
| CRP on POD 3 (mg/L) | 124.8 ± 36.2 | 98.6 ± 28.5 | 3.964 | < 0.001 |
| CRP on POD 5 (mg/L) | 68.4 ± 22.6 | 48.2 ± 18.3 | 4.832 | < 0.001 |
| IL-6 on POD 3 (pg/mL) | 168.5 ± 52.3 | 128.6 ± 42.8 | 4.112 | < 0.001 |
| IL-6 on POD 5 (pg/mL) | 86.2 ± 28.4 | 62.5 ± 21.6 | 4.611 | < 0.001 |
Table 3 Comparison of hemodynamic parameters between two groups, mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | t value | P value |
| MAP at 12 hours (mmHg) | 74.8 ± 9.2 | 78.6 ± 7.4 | 2.243 | 0.027 |
| MAP at 24 hours (mmHg) | 76.2 ± 8.4 | 80.8 ± 6.8 | 2.954 | 0.004 |
| MAP at 48 hours (mmHg) | 78.5 ± 7.6 | 82.4 ± 5.9 | 2.808 | 0.006 |
| HR at 24 hours (bpm) | 92.4 ± 12.6 | 86.2 ± 10.4 | 2.636 | 0.010 |
| HR at 48 hours (bpm) | 88.2 ± 10.8 | 82.6 ± 8.6 | 2.812 | 0.006 |
Table 4 Comparison of sedation and pain assessment between two groups, mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | Statistic | P value |
| Time to target sedation (hours) | 3.8 ± 1.4 | 2.6 ± 1.1 | t = 4.692 | < 0.001 |
| CPOT at 6 hours | 2.4 ± 0.8 | 1.8 ± 0.6 | t = 4.167 | < 0.001 |
| CPOT at 24 hours | 1.9 ± 0.7 | 1.4 ± 0.5 | t = 4.037 | < 0.001 |
| Total opioid (MEQ mg) | 168.4 ± 42.6 | 124.8 ± 35.2 | t = 5.486 | < 0.001 |
Table 5 Comparison of organ function indicators between two groups, mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | t value | P value |
| PaO2/FiO2 on admission (mmHg) | 186.4 ± 42.8 | 182.6 ± 45.2 | 0.424 | 0.672 |
| PaO2/FiO2 on POD 3 (mmHg) | 218.6 ± 48.5 | 256.4 ± 52.8 | 3.676 | < 0.001 |
| PaO2/FiO2 on POD 5 (mmHg) | 268.4 ± 54.2 | 312.6 ± 48.6 | 4.215 | < 0.001 |
| Creatinine on POD 3 (μmol/L) | 128.6 ± 32.4 | 108.2 ± 28.6 | 3.281 | 0.001 |
| Creatinine on POD 5 (μmol/L) | 102.4 ± 26.8 | 86.5 ± 22.4 | 3.163 | 0.002 |
| SOFA on POD 3 | 5.4 ± 1.8 | 4.2 ± 1.5 | 3.561 | < 0.001 |
| SOFA on POD 5 | 3.8 ± 1.4 | 2.6 ± 1.2 | 4.522 | < 0.001 |
Table 6 Comparison of lactate metabolism between two groups, mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | t value | P value |
| Lactate on admission (mmol/L) | 4.8 ± 1.6 | 4.6 ± 1.5 | 0.634 | 0.528 |
| Lactate at 12 hours (mmol/L) | 3.6 ± 1.2 | 2.8 ± 0.9 | 3.712 | < 0.001 |
| Lactate at 24 hours (mmol/L) | 2.9 ± 1.0 | 2.1 ± 0.7 | 4.542 | < 0.001 |
| Lactate at 48 hours (mmol/L) | 2.2 ± 0.8 | 1.6 ± 0.5 | 4.412 | < 0.001 |
| 24h lactate clearance rate (%) | 38.6 ± 14.8 | 52.8 ± 12.4 | 5.102 | < 0.001 |
| Time to lactate normalization (hours) | 46.8 ± 14.2 | 32.4 ± 10.6 | 5.632 | < 0.001 |
Table 7 Comparison of clinical outcomes between two groups, n (%)/mean ± SD
| Item | Control group (n = 49) | Intervention group (n = 49) | Statistic | P value |
| ICU LOS (days) | 6.8 ± 2.4 | 5.2 ± 1.9 | t = 3.643 | < 0.001 |
| MV duration (hours) | 48.6 ± 18.4 | 36.2 ± 14.6 | t = 3.668 | < 0.001 |
| 28-day mortality | 4 (8.2) | 3 (6.1) | χ2 = 0.154 | 0.695 |
| Delirium incidence | 12 (24.5) | 4 (8.2) | χ2 = 4.653 | 0.031 |
| Respiratory depression | 3 (6.1) | 2 (4.1) | χ2 = 0.211 | 0.646 |
| Bradycardia | 2 (4.1) | 6 (12.2) | χ2 = 1.965 | 0.161 |
- Citation: Men LC, Wang LZ, Ma CY, Zhang Y, Han Y. Oxycodone-dexmedetomidine vs fentanyl analgesia in septic patients after gastric perforation surgery. World J Gastrointest Surg 2026; 18(8): 120491
- URL: https://www.wjgnet.com/1948-9366/full/v18/i8/120491.htm
- DOI: https://dx.doi.org/10.4240/wjgs.120491